Drug Research Group Inc

Analysis

Drug Research Group Inc is a registered charity in United States, based in Lexington, MA. It received its IRS tax-exemption ruling in June 1983, 43 years ago. Its declared purposes cover health care, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending June 2023, Drug Research Group Inc reported income of $576k and spending of $997k, spending 173% of what it took in. Across the 5 years on record, from June 2019 to June 2023, income fell from $1.2m to $576k (-52%), an average of -17% a year. The sharpest change came in the year to June 2023, when income rose by 126%. Over the whole period it spent 120% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Drug Research Group Inc sits at the 57th percentile: it is larger than about 57% of them. Against every charity in United States with reported income it ranks in the 72nd percentile, and in the 72nd percentile within MA. Charities of a similar size with the same main cause include Quality Living Center Inc ($576k), Granite House Inc ($577k) and Arlington Lions Foundation Inc ($576k).

On its Form 990 for the period ending June 2023, revenue came from contributions and grants 99% of the total. Compensation of current officers, directors and key employees was $95k (9.5% of expenses). Other salaries and wages came to $418k. At year end it held assets of $879k against liabilities of $34k, net assets of $845k. It reported 10 employees.